Candriam S.C.A. Veracyte, Inc. Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Veracyte, Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 231,676 shares of VCYT stock, worth $10 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

231,676

Previous 670,937 65.47%

Holding current value

$10 Million

Previous $14.5 Million 45.78%

% of portfolio

0.05%

Previous 0.09%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$21.0 - $35.25 $9.22 Million - $15.5 Million	-439,261 Reduced 65.47%	231,676 $7.88 Million
Q1 2024 May 03, 2024	BUY	$21.0 - $29.1 $1.26 Million - $1.75 Million	60,005 Added 9.82%	670,937 $14.9 Million
Q4 2023 Feb 14, 2024	BUY	$19.72 - $28.68 $12 Million - $17.5 Million	610,932 New	610,932 $16.8 Million
Q2 2023 Aug 08, 2023	SELL	$20.96 - $26.99 $444,771 - $572,727	-21,220 Reduced 3.41%	600,926 $15.3 Million
Q1 2023 May 12, 2023	BUY	$20.58 - $27.89 $411,599 - $557,800	20,000 Added 3.32%	622,146 $13.9 Million
Q4 2022 Feb 13, 2023	BUY	$15.31 - $29.94 $3.42 Million - $6.69 Million	223,483 Added 59.02%	602,146 $14.3 Million
Q1 2022 May 13, 2022	BUY	$21.94 - $42.51 $8.31 Million - $16.1 Million	378,663 New	378,663 $10.4 Million
Q4 2020 Jan 22, 2021	SELL	$32.49 - $61.88 $6.58 Million - $12.5 Million	-202,595 Closed	0 $0
Q3 2020 Oct 19, 2020	SELL	$26.73 - $35.67 $171,606 - $229,001	-6,420 Reduced 3.07%	202,595 $6.58 Million
Q2 2020 Jul 23, 2020	BUY	$19.49 - $28.11 $888,568 - $1.28 Million	45,591 Added 27.9%	209,015 $5.41 Million
Q1 2020 May 26, 2020	BUY	$16.13 - $30.17 $532 - $995	33 Added 0.02%	163,424 $4.46 Million
Q4 2019 Jan 21, 2020	BUY	$20.78 - $29.99 $1.5 Million - $2.17 Million	72,329 Added 79.43%	163,391 $5,000
Q3 2019 Oct 21, 2019	BUY	$23.87 - $30.93 $226,765 - $293,835	9,500 Added 11.65%	91,062 $2,000
Q2 2019 Aug 01, 2019	BUY	$22.1 - $28.56 $433,160 - $559,776	19,600 Added 31.63%	81,562 $2.32 Million
Q1 2019 May 02, 2019	BUY	$12.0 - $25.76 $743,544 - $1.6 Million	61,962 New	61,962 $1.55 Million

Others Institutions Holding VCYT

# of Institutions

308

Shares Held

81.8M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.1B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account